Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 4-aminopyridine improves freezing of gait in Parkinson's disease.

Literature DB >> 23989346

4-aminopyridine improves freezing of gait in Parkinson's disease.

Corneliu C Luca¹, Carlos Singer.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 23989346 DOI： 10.1007/s00415-013-7090-0

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

12 in total

Review 1. 4-aminopyridine and cerebellar gait: a retrospective case series.

Authors: Roman Schniepp; Max Wuehr; Maximilian Neuhaeusser; Ann Kathrin Benecke; Christine Adrion; Thomas Brandt; Michael Strupp; Klaus Jahn
Journal: J Neurol Date: 2012-07-04 Impact factor: 4.849

2. Milestones in gait, balance, and falling.

Authors: John G Nutt; Fay B Horak; Bastiaan R Bloem
Journal: Mov Disord Date: 2011-05 Impact factor: 10.338

3. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Authors: M Strupp; R Kalla; J Claassen; C Adrion; U Mansmann; T Klopstock; T Freilinger; H Neugebauer; R Spiegel; M Dichgans; F Lehmann-Horn; K Jurkat-Rott; T Brandt; J C Jen; K Jahn
Journal: Neurology Date: 2011-07-06 Impact factor: 9.910

4. Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease.

Authors: James M Shine; Elie Matar; Philip B Ward; Samuel J Bolitho; Moran Gilat; Mark Pearson; Sharon L Naismith; Simon J G Lewis
Journal: Brain Date: 2013-03-12 Impact factor: 13.501

5. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.

Authors: Kathryn A Chung; Brenna M Lobb; John G Nutt; Fay B Horak
Journal: Neurology Date: 2010-09-01 Impact factor: 9.910

6. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

Authors: Caroline Moreau; Arnaud Delval; Luc Defebvre; Kathy Dujardin; Alain Duhamel; Gregory Petyt; Isabelle Vuillaume; Jean-Christophe Corvol; Christine Brefel-Courbon; Fabienne Ory-Magne; Dominique Guehl; Alexandre Eusebio; Valérie Fraix; Pierre-Jean Saulnier; Ouhaid Lagha-Boukbiza; Frank Durif; Mirela Faighel; Caroline Giordana; Sophie Drapier; David Maltête; Christine Tranchant; Jean-Luc Houeto; Bettina Debû; Bernard Sablonniere; Jean-Philippe Azulay; François Tison; Olivier Rascol; Marie Vidailhet; Alain Destée; Bastiaan R Bloem; Régis Bordet; David Devos
Journal: Lancet Neurol Date: 2012-06-01 Impact factor: 44.182

4-aminopyridine improves freezing of gait in Parkinson's disease.

Review 1. 4-aminopyridine and cerebellar gait: a retrospective case series.

2. Milestones in gait, balance, and falling.

3. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

4. Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease.

5. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.

6. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

7. Amantadine improves gait in PD patients with STN stimulation.

8. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.

9. Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine.

Review 10. Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy).

1. Potent block of potassium channels by MEK inhibitor U0126 in primary cultures and brain slices.